| (6aR,9R,10aR)-7-allyl-N-(3-(dimethylamino)propyl)-N-(ethylcarbamoyl)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide |
| (8beta)-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-(prop-2-en-1-yl)ergoline-8-carboxamide |
| (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide |
| (8beta)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-prop-2-en-1-ylergoline-8-carboxamide |
| (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide |
| 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea |
| 1-[(6-Allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)-propyl]-3-ethylurea |
| 1-[(6-allylergoline-8beta-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea |
| 1-[3-(dimethylamino)propyl]-3-ethyl-1-[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene-4-carbonyl]urea |
| 1-[3-(DIMETHYLAMINO)PROPYL]-3-ETHYL-1-[(2R,4R,7R)-6-(PROP-2-EN-1-YL)-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),9,12(16),13-TETRAENE-4-CARBONYL]UREA |
| 1-[3-(dimethylamino)propyl]-3-ethyl-1-{[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]carbonyl}urea |
| 1-[3-(dimethylamino)propyl]-3-ethyl-1-{[(2R,4R,7R)-6-(prop-2-en-1-yl)-6,11-diazatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]carbonyl}urea |
| 1-ethyl-2-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-carbonyl)urea diphosphate |
| 1-Ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'beta-carbonyl)urea |
| 1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'beta-carbonyl)urea |
| 409C907 |
| 6-allyl-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-ergoline-8beta-carboxamide |
| 81409-90-7 |
| 85329-89-1 (diphosphate) |
| AB01275484-01 |
| AC-26126 |
| AC1L1HO0 |
| AC1Q5OQ0 |
| AKOS015961587 |
| AN-36255 |
| BC207368 |
| BDBM50426497 |
| BIDD:GT0775 |
| BRD-K86882815-001-01-6 |
| BRN 6020775 |
| C08187 |
| C26H37N5O2 |
| Cabaser |
| Cabaser (TN) |
| Cabaseril |
| Cabergolina |
| Cabergolina [Spanish] |
| Cabergoline (JAN/USAN/INN) |
| Cabergoline [USAN:BAN:INN] |
| Cabergoline, >=98% (HPLC) |
| Cabergoline, European Pharmacopoeia (EP) Reference Standard |
| Cabergoline, United States Pharmacopeia (USP) Reference Standard |
| Cabergolinum |
| Cabergolinum [Latin] |
| Caberlin |
| CAS-81409-90-7 |
| CG-101 |
| CHEBI:3286 |
| CHEMBL1201087 |
| CTK8F8406 |
| D00987 |
| D04EGX |
| DB00248 |
| Dostinex |
| Dostinex (TN) |
| DR002797 |
| DSSTox_CID_2719 |
| DSSTox_GSID_22719 |
| DSSTox_RID_76698 |
| DTXSID6022719 |
| Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-beta)- |
| Ergoline-8beta-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)- |
| FCE-21336 |
| FT-0081285 |
| FT-0650562 |
| Galastop |
| GTPL37 |
| HMS2090A09 |
| K450 |
| KORNTPPJEAJQIU-KJXAQDMKSA-N |
| LL60K9J05T |
| LS-64370 |
| MFCD00867887 |
| MolPort-003-845-557 |
| N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)-6-allyl-ergoline-8beta-carboxamide |
| NCGC00167821-01 |
| NCGC00344544-01 |
| PL070592 |
| SC-19831 |
| SCHEMBL42292 |
| Sogilen |
| SR-05000001493 |
| SR-05000001493-2 |
| Tox21_112589 |
| Tox21_112589_1 |
| UNII-LL60K9J05T |
| ZINC3800008 |
